study_title: The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD

study_first_author: Greaney

study_year: 2021

study_journal: bioRxiv

study_url: https://www.biorxiv.org/content/10.1101/2021.04.14.439844v1

spike: Wuhan-Hu-1

notes: "Data taken from here https://github.com/jbloomlab/SARS-CoV-2-RBD_MAP_Moderna/blob/main/results/supp_data/Moderna_sera_raw_data.csv after removing antibodies and sera that are duplicated in that file from prior studies for re-plotting."

conditions:
  M01 (day 119): &vaccine_serum
    type: serum
    subtype: Moderna vaccine serum
    year: 2020
    notes: null
  M02 (day 119): *vaccine_serum
  M03 (day 119): *vaccine_serum
  M04 (day 119): *vaccine_serum
  M05 (day 119): *vaccine_serum
  M06 (day 119): *vaccine_serum
  M07 (day 119): *vaccine_serum
  M08 (day 119): *vaccine_serum
  M09 (day 119): *vaccine_serum
  M10 (day 119): *vaccine_serum
  M11 (day 119): *vaccine_serum
  M12 (day 119): *vaccine_serum
  M13 (day 119): *vaccine_serum
  M14 (day 119): *vaccine_serum
  M15 (day 119): *vaccine_serum
  M16 (day 119): *vaccine_serum
  M17 (day 119): *vaccine_serum
  M18 (day 119): *vaccine_serum
  M19 (day 119): *vaccine_serum
  M20 (day 119): *vaccine_serum
  M21 (day 119): *vaccine_serum
  M22 (day 119): *vaccine_serum
  M23 (day 119): *vaccine_serum
  M02 (day 36): *vaccine_serum
  M05 (day 36): *vaccine_serum
  M08 (day 36): *vaccine_serum
  M10 (day 36): *vaccine_serum
  M12 (day 36): *vaccine_serum
